PERFORMANCE OF A METHOD FOR QUANTIFYING PROGRANULIN AS A TARGET ENGAGEMENT BIOMARKER FOR AZP2006 IN PROGRESSIVE SUPRANUCLEAR PALSY

ezeprogind (AZP2006) - AlzProtect

https://cslide.ctimeetingtech.com/global_storage/media/content/adpd24/ADPD24_-_Posters_for_website_NOV_23.pdf

Cécilia Estrella1; Aurélien Blondel1; Philippe Verwaerde1; Noëlle Callizot1; Renaud Jasnowski2; Audrey Pabiou2; Aurélie Chene2; Cendrine Josson2; Christine Bain2

Feb 16, 2024